Ownership and insider activity for Anteris Technologies Global Corp. (AVR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve.
Price
| Price | $8.16 |
| Market Cap | $793M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-11 | Moen Brent | A-Award | 90,274 | $754K |
| 2026-09-11 | Moen Brent | |||
| 2026-08-28 | L1 Capital Pty Ltd | S-Sale | 7,800 | $69K |
| 2026-08-19 | St Denis David | M-Exempt | 60,000 | $339K |
| 2026-08-19 | St Denis David | F-InKind | 45,072 | $432K |
| 2026-08-19 | St Denis David | M-Exempt | 60,000 | $339K |
| 2026-08-10 | L1 Capital Pty Ltd | S-Sale | 251,844 | $2.3M |
| 2026-08-11 | L1 Capital Pty Ltd | S-Sale | 375,815 | $3.5M |
| 2026-08-06 | L1 Capital Pty Ltd | S-Sale | 174,721 | $1.4M |
| 2026-08-04 | L1 Capital Pty Ltd | S-Sale | 480,608 | $4.0M |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.4M | $15.5M | $9.4M | $21.1M | $70.5M | $12.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $652395 | $1.9M | $563677 | $1.1M | $383000 | $32000 |
| Inventory | $534667 | $549820 | $355624 | $442348 | $513000 | $735000 |
| Total Current Assets | $6.2M | $18.7M | $12.2M | $24.2M | $74.7M | $15.7M |
| Property, Plant & Equipment | $1.9M | $1.9M | $3.1M | $5.5M | $5.9M | $7.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $1.1M | $763643 | $607354 | $410146 | $189000 | $65000 |
| Total Assets | $9.8M | $21.4M | $16.0M | $30.5M | $80.7M | $23.0M |
| Accounts Payable | $581865 | $2.2M | $1.7M | $3.1M | $5.9M | $11.1M |
| Short-term Debt | $2.0M | $3.4M | $513009 | $668921 | $3000 | $582000 |
| Total Current Liabilities | $6.0M | $10.2M | $6.0M | $9.5M | $16.6M | $21.4M |
| Long-term Debt | 0 | 0 | $8695 | $97961 | 0 | $22000 |
| Total Liabilities | $7.9M | $10.9M | $7.0M | $11.6M | $18.0M | $23.2M |
| Retained Earnings | -$103.9M | -$123.5M | -$154.1M | -$200.1M | -$276.4M | -$370.5M |
| Total Equity | $1.9M | $10.5M | $9.0M | $19.3M | $62.8M | -$93000 |
| Total Debt | $2.9M | $4.1M | $952787 | $1.7M | $1.4M | $2.3M |
| Net Debt | -$440556 | -$11.3M | -$8.4M | -$19.4M | -$69.1M | -$10.3M |
| Working Capital | $195348 | $8.6M | $6.2M | $14.8M | $58.1M | -$5.7M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 14.20 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -31.49 |
Profitability
| Return on Equity | -77.66% |
| Return on Invested Capital | -41.63% |
| Return on Assets | -38.01% |
| Gross Margin | 36.98% |
| Operating Margin | -4738.36% |
| Net Margin | -4619.67% |
Related companies: ANIK · ARAY · ATLN · CYBN · LNSR · LUCD · MXCT
Explore sector: Healthcare · Medical - Devices
More sections of AVR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks